Optimizing assessments of quality of life in contemporary prostate cancer clinical trials

Cancer. 2024 Oct 15;130(20):3406-3408. doi: 10.1002/cncr.35485. Epub 2024 Jul 27.

Author

Alicia K Morgans¹

Affiliation

¹ Department of Medicine, Harvard Medical School and Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

PMID: 39072757
DOI: 10.1002/cncr.35485

No abstract available

Publication types

Editorial

MeSH terms

Clinical Trials as Topic* / standards
Humans
Male
Prostatic Neoplasms* / psychology
Prostatic Neoplasms* / therapy
Quality of Life*